Anti-GALNT7 Antibody

Polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) is a Golgi-resident enzyme that initiates mucin-type O-linked glycosylation by transferring N-acetylgalactosamine from UDP-GalNAc onto serine and threonine residues of substrate proteins. This unconjugated Rabbit polyclonal antibody from Antibodies.com is raised against the human GALNT7 target and supplied as 100 µl of polyclonal antiserum in a single vial, validated for western blot, immunohistochemistry, and immunofluorescence staining workflows.

Researchers use this reagent to probe GALNT7 expression across cultured human cell lines and formalin-fixed tissue specimens, supporting investigations of glycoprotein biosynthesis, mucin biology, and signaling pathways where aberrant O-GalNAc glycosylation has been linked to tumor progression. As an unconjugated primary antibody, it accepts any laboratory-preferred secondary reporter, allowing flexible pairing with HRP, biotin, or fluorescent secondaries depending on whether the application is chromogenic immunohistochemistry, chemiluminescent western blot, or fluorescent imaging.

To preserve activity, aliquot the antiserum upon arrival to limit freeze-thaw cycles and follow the storage conditions specified on the product datasheet. The reagent is intended for research use only and is not validated for diagnostic or therapeutic use.